Open Access Crystallographic studies of the anthrax lethal toxin

Authors: Liddington, R.1; Pannifer, A.1; Hanna, P.2; Leppla, S.3; Collier, R. J.4

Source: Journal of Applied Microbiology, Volume 87, Number 2, August 1999 , pp. 282-282(1)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

You have access to the full text article on a website external to ingentaconnect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library

Abstract:

Anthrax lethal toxin comprises two proteins: protective antigen (PA; MW 83 kDa) and lethal factor (LF; MW 87 kDa). We have recently determined the crystal structure of the 735-residue PA in its monomeric and heptameric forms ( Petosa et al. 1997 ). It bears no resemblance to other bacterial toxins of known three-dimensional structure, and defines a new structural class which includes homologous toxins from other Gram-positive bacteria. We have proposed a model of membrane insertion in which the water-soluble heptamer undergoes a substantial pH-induced conformational change involving the creation of a 14-stranded β-barrel. Recent work by Collier's group ( Benson et al. 1998 ) lends strong support to our model of membrane insertion. `Lethal factor' is the catalytic component of anthrax lethal toxin. It binds to the surface of the cell-bound PA heptamer and, following endocytosis and acidification of the endosome, translocates to the cytosol. We have made substantial progress towards an atomic resolution crystal structure of LF. Progress towards a structure of the 7:7 translocation complex between the PA heptamer and LF will also be discussed.

Document Type: Research article

DOI: http://dx.doi.org/10.1046/j.1365-2672.1999.00888.x

Affiliations: 1: Department of Biochemistry, University of Leicester, Leicester, UK, 2: Duke University Medical Center, Durham, NC, 3: Laboratory of Microbial Ecology, National Institutes of Health, Bethesda, MD and 4: Department of Microbiology & Molecular Genetics, Harvard Medical School, Boston, MA, USA

Publication date: 1999-08-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page